Claraphi Advisory Network’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,784
Closed -$777K 298
2021
Q4
$777K Buy
5,784
+348
+6% +$50K 0.27% 88
2021
Q3
$743K Buy
+5,436
New +$686K 0.26% 87
2020
Q4
Sell
-2,516
Closed -$259K 286
2020
Q3
$259K Sell
2,516
-3,220
-56% -$336K 0.09% 188
2020
Q2
$582K Buy
5,736
+4,600
+405% +$411K 0.25% 77
2020
Q1
$77K Buy
+1,136
New +$70.7K 0.04% 389

Other funds holding DXCM

Claraphi Advisory Network's DXCM Position: Q1 2022 in Review

Claraphi Advisory Network sold out of DexCom (DXCM) in Q1 2022, closing a stake of 5,784 shares — an estimated $777K sold.

Claraphi Advisory Network first reported a position in DXCM in Q1 2020 and held it in 5 quarters. The position peaked at $777K in Q4 2021. 861 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • Claraphi Advisory Network reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
  • Claraphi Advisory Network sold 5,784 DexCom shares in Q1 2022, an estimated $777K.
  • Claraphi Advisory Network first reported a position in DexCom in Q1 2020 and held it in 5 quarters.
  • Claraphi Advisory Network's DexCom position peaked at $777K in Q4 2021.
  • 861 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Claraphi Advisory Network's 13F filing for Q1 2022, filed 12 May 2022.